Keel Point’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,510
Closed -$446K 522
2026
Q1
$446K Buy
1,510
+52
+4% +$15.4K 0.03% 282
2025
Q4
$398K Sell
1,458
-111
-7% -$30.2K 0.02% 348
2025
Q3
$424K Buy
1,569
+146
+10% +$39.7K 0.03% 335
2025
Q2
$392K Buy
1,423
+127
+10% +$34.5K 0.03% 349
2025
Q1
$344K Sell
1,296
-93
-7% -$22.9K 0.03% 326
2024
Q4
$323K Buy
1,389
+151
+12% +$34.7K 0.03% 316
2024
Q3
$273K Buy
1,238
+43
+4% +$8.9K 0.02% 346
2024
Q2
$248K Buy
1,195
+184
+18% +$38K 0.02% 361
2024
Q1
$218K Buy
+1,011
New +$212K 0.02% 348

Other funds holding CME

Keel Point's CME Position: Q2 2026 in Review

Keel Point sold out of CME Group (CME) in Q2 2026, closing a stake of 1,510 shares — an estimated $446K sold.

Keel Point first reported a position in CME in Q1 2024 and held it in 9 quarters. The position peaked at $446K in Q1 2026. 1,702 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Keel Point reported no remaining CME Group position as of Q2 2026 after selling out during the quarter.
  • Keel Point sold 1,510 CME Group shares in Q2 2026, an estimated $446K.
  • Keel Point first reported a position in CME Group in Q1 2024 and held it in 9 quarters.
  • Keel Point's CME Group position peaked at $446K in Q1 2026.
  • 1,702 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Keel Point's 13F filing for Q2 2026, filed 14 Aug 2026.